Changjiang Runfa Health Industry Co., Ltd. Stock

Equities

002435

CNE100000QC7

Heavy Electrical Equipment

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
2.65 CNY -3.28% Intraday chart for Changjiang Runfa Health Industry Co., Ltd. -12.83% -36.45%
Sales 2021 4.37B 604M Sales 2022 3.47B 479M Capitalization 5.77B 797M
Net income 2021 -413M -57.04M Net income 2022 65M 8.98M EV / Sales 2021 1.36 x
Net cash position 2021 563M 77.7M Net cash position 2022 658M 90.87M EV / Sales 2022 1.47 x
P/E ratio 2021
-15.8 x
P/E ratio 2022
88.6 x
Employees 2,405
Yield 2021 *
-
Yield 2022
-
Free-Float 45.51%
More Fundamentals * Assessed data
Dynamic Chart
Changjiang Runfa Health Industry Co., Ltd. Approves Board Elections CI
Changjiang Runfa Health Unit's Antibacterial Drug Passes Drug Regulator's Consistency Evaluation MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Changjiang Runfa Health Industry Co., Ltd.(XSEC:002435) added to S&P Global BMI Index CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. completed the acquisition of 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Rongtong No. 5 Securities Investment Fund, managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire a 5.99% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. agreed to acquire 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. for approximately CNY310 million. CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Changjiang Runfa Health Boosts Stake in Jianghe Pharmaceutical to 87% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Changjiang Runfa Health Buys 58% of Peer for 39 Million Yuan; Shares Rally 10% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Changjiang Runfa Health's Shareholder and Parties Acting in Concert Plan to Cut Stakes CI
More news
1 day-3.28%
1 week-12.83%
Current month-15.61%
1 month-18.46%
3 months-33.58%
6 months-40.85%
Current year-36.45%
More quotes
1 week
2.55
Extreme 2.55
3.01
1 month
2.55
Extreme 2.55
3.41
Current year
2.38
Extreme 2.38
4.26
1 year
2.38
Extreme 2.38
5.04
3 years
2.38
Extreme 2.38
9.89
5 years
2.38
Extreme 2.38
9.89
10 years
2.38
Extreme 2.38
9.89
More quotes
Managers TitleAgeSince
Director of Finance/CFO 52 19-04-22
President 50 19-04-22
Director/Board Member 46 07-10-21
Members of the board TitleAgeSince
Director/Board Member 60 07-10-21
Chairman 61 07-10-21
Director/Board Member 83 07-10-21
More insiders
Date Price Change Volume
24-04-18 2.65 -3.28% 14,715,900
24-04-17 2.74 +7.45% 16,165,010
24-04-16 2.55 -9.89% 22,396,240
24-04-15 2.83 -5.67% 17,517,600
24-04-12 3 -1.32% 8,747,232

End-of-day quote Shenzhen S.E., April 17, 2024

More quotes
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Company’s products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002435 Stock